{"url":"https://newsforagent.com/news/2026-11-05/ramsay-sante-first-quarter-revenue-growth","markdown_url":"https://newsforagent.com/news/2026-11-05/ramsay-sante-first-quarter-revenue-growth.md","title":"Ramsay Santé Q1 Revenue Rises 2.9% to €1.23 Billion","headline":"Ramsay Santé Posts 2.9% Revenue Growth and 7.5% EBITDA Gain in First Quarter","description":"Ramsay Santé reported first-quarter revenue of €1.23 billion, up 2.9%, and EBITDA of €120.7 million, up 7.5%.","section":"Earnings & Results","published_at":"2026-11-05T16:51:57+00:00","modified_at":"2026-11-05T16:51:57+00:00","author":"News Desk","key_takeaways":["Ramsay Santé's first-quarter revenue rose 2.9% to €1,232.9 million, with EBITDA up 7.5% to €120.7 million.","Pre-IFRS16 restated net leverage improved to 5.1x from 5.2x a year earlier, and net financial debt stood at €3,730 million.","Ramsay Santé will hold a conference call and live webcast on 6 November 2026 at 8:00am CET."],"companies":[{"name":"Ramsay Santé","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00054tj/ramsay-sante","website":"https://www.ramsayhealth.com"}],"source":{"publisher":"GlobeNewswire","title":"RAMSAY SANTE : Unaudited interim results at the end of September 2026","url":"https://www.globenewswire.com/news-release/2026/11/05/3396832/0/en/ramsay-sante-unaudited-interim-results-at-the-end-of-september-2026.html"},"other_sources":[],"tags":["Earnings & Results","Ramsay Santé"],"body_markdown":"[Ramsay Santé](https://akta.pro/company-profiles/00054tj/ramsay-sante) reported first-quarter revenue of €1,232.9 million, up 2.9% from €1,198.6 million a year earlier, and EBITDA of €120.7 million, up 7.5%, for the quarter ended September 30, 2026. The Paris-based private hospital and primary care operator, which runs 492 facilities across five countries, released the unaudited figures in a [GlobeNewswire](https://www.globenewswire.com/news-release/2026/11/05/3396832/0/en/ramsay-sante-unaudited-interim-results-at-the-end-of-september-2026.html) press release on November 5, 2026.\n\n## Ramsay Santé's First-Quarter Revenue and EBITDA\n\nRevenue growth was 2.6% at constant exchange rates and 2.8% on an organic basis. France contributed €832.8 million, up 1.9%, and the Nordic countries €400.1 million, up 4.9%. French admissions in medicine, surgery and obstetrics rose 4.1% year-on-year, driven by ambulatory care, and the group's French facilities treated approximately 170,000 emergency patients in the quarter.\n\nEBITDA rose by €8.4 million to €120.7 million, lifting the margin to 9.8% from 9.4%. The group's share of net loss was €35.5 million, compared with €40.1 million a year earlier. Net cash flow from operating activities improved by €40 million year-on-year to €(3) million.\n\nPascal Roché, CEO of Ramsay Santé, said: \"The first quarter of our financial year reinforces the strong momentum we have built over recent periods. We delivered solid revenue growth and further improved our operating margin, despite a challenging operating environment.\"\n\n## Ramsay Santé's Debt Position and Refinancing\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Ramsay Santé launched a €1.75 billion senior debt refinancing comprising a €200 million revolving credit facility and a €1.55 billion Term Loan B, extending senior debt maturities from 2031 to 2033. The company said the refinancing closed on July 22, 2026, and was priced at E+350bps / 99.0 OID.\n\nNet financial debt was €3,730 million at September 30, 2026, including €1,788 million of restated pre-IFRS16 net debt. Restated net leverage improved to 5.1x from 5.2x as of September 30, 2025. Ramsay Santé maintained its short and mid-term financial outlook.\n\n## Ramsay Santé's Path to a New Shareholder Base\n\nRamsay Health Care plans to distribute its 52.79% stake in Ramsay Santé to its own shareholders, with the distribution planned for December 9, 2026, subject to approval by Ramsay Health Care shareholders at their General Meeting on November 24, 2026 and receipt of the required authorisations, EIN Presswire reported in October 2026.\n\nRamsay Santé's Board is preparing to renew the group's governance ahead of the planned distribution. It has proposed the appointments of Frédéric Collet as independent Chairman, Pascal Roché and Alexandra Boleslawski as Directors, and Virginie Banet and Alexandre de Palmas as independent Directors at the General Meeting on December 4, 2026.\n\n## Ramsay Santé's Next Steps\n\nRamsay Santé will hold a conference call and live webcast on November 6, 2026 at 8:00am CET. The proposed board appointments are subject to shareholder approval at the General Meeting on December 4, 2026 and would take effect on completion of the distribution.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}